These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30899214)

  • 1. Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders.
    Telias M
    Front Mol Neurosci; 2019; 12():51. PubMed ID: 30899214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1
    Lundbye CJ; Toft AKH; Banke TG
    J Physiol; 2018 Oct; 596(20):5017-5031. PubMed ID: 30132892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
    Berry-Kravis E
    Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
    Mol Autism; 2016; 7():17. PubMed ID: 26933487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction.
    Telias M
    Curr Pharm Des; 2019; 25(41):4394-4404. PubMed ID: 31682210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability.
    Susco SG; Arias-García MA; López-Huerta VG; Beccard A; Bara AM; Moffitt J; Korn J; Fu Z; Barrett LE
    Dev Biol; 2020 Dec; 468(1-2):93-100. PubMed ID: 32976839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
    Gerhardt J
    Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling fragile X syndrome in the Fmr1 knockout mouse.
    Kazdoba TM; Leach PT; Silverman JL; Crawley JN
    Intractable Rare Dis Res; 2014 Nov; 3(4):118-33. PubMed ID: 25606362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.
    Toft AK; Lundbye CJ; Banke TG
    J Neurosci; 2016 Sep; 36(38):9817-27. PubMed ID: 27656021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
    Kumari D; Swaroop M; Southall N; Huang W; Zheng W; Usdin K
    Stem Cells Transl Med; 2015 Jul; 4(7):800-8. PubMed ID: 25999519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.
    Martinez LA; Tejada-Simon MV
    Mol Neurobiol; 2018 Jun; 55(6):4529-4542. PubMed ID: 28688003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
    Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
    J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal dysfunction and cognitive impairment in Fragile-X Syndrome.
    Bostrom C; Yau SY; Majaess N; Vetrici M; Gil-Mohapel J; Christie BR
    Neurosci Biobehav Rev; 2016 Sep; 68():563-574. PubMed ID: 27345143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens.
    Frederikse PH; Nandanoor A; Kasinathan C
    Neurochem Res; 2015 Nov; 40(11):2167-76. PubMed ID: 26298628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.